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ABSTRACT
Premenopausal breast cancer is associated with increased animal fat 
consumption among normal weight, but not overweight women (Farvid et al., 2014). 
Our previous findings in obesity-resistant BALB/c mice similarly showed promotion 
of carcinogen-induced mammary tumorigenesis by a diet high in saturated animal 
fat (HFD). This effect was specific to pubertal versus adult HFD. This study identifies 
the effects of HFD during puberty versus adulthood in Trp53-null transplant BALB/c 
mice and investigates its mechanism of enhancing tumorigenesis. Either pubertal or 
adult HFD is sufficient to increase incidence of Trp53-null mammary tumors. Puberty-
restricted HFD exposure promoted tumor cell proliferation, increased angiogenesis, 
and increased recruitment of total and M2 macrophages in epithelial tumors. Adult-
restricted exposure to HFD similarly increased proliferation, angiogenesis, recruitment 
of total and M2 macrophages, and additionally reduced apoptosis. Adult HFD also 
increased incidence of spindle cell carcinomas resembling claudin-low breast cancer, 
and thus adult HFD in the Trp53-null transplantation system may be a useful model 
for human claudin low breast cancer. Importantly, these results on Trp53-null and 
our prior studies on DMBA-induced mammary tumorigenesis demonstrate a pubertal 
window of susceptibility to the promotional effects of HFD, indicating the potential 
of early life dietary intervention to reduce breast cancer risk.
INTRODUCTION
Effective prevention strategies are needed to 
combat breast cancer. Lifestyle modifications, especially 
changes in diet, have been heavily investigated as 
potential preventative measures. Some studies reported 
that a western diet, rich in saturated fat, is associated with 
increased breast cancer risk [1]. However, meta-analyses 
examining the association of total fat and saturated 
fat intake with breast cancer risk are inconsistent, 
partly because of differences in study design, dietary 
classification, dietary assessment at the time of cancer 
diagnosis, and varied baseline breast cancer incidence 
among the diverse populations studied [2-6]. The 
interaction of fat intake with breast cancer risk may also 
be subtype specific [7]. While high fat diet (HFD) often 
leads to obesity, a recent analysis of the Nurses’ Health 
Study II identified consumption of a high animal fat diet 
in early adulthood to increase pre-menopausal breast 
cancer risk only in normal weight women, suggesting 
that dietary effects in tumor promotion may be obesity 
independent [8].
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Human and rodent models have demonstrated that 
the mammary gland is sensitive to environmental and 
dietary influences during puberty [9, 10]. We previously 
reported that life-long exposure to HFD initiated in 
puberty compared to a life-long low fat diet (LFD) [11] 
or HFD restricted to puberty [12] similarly reduced the 
latency of 7,12-dimethylbenz[a]anthracene (DMBA)-
induced tumors. Mice overexpressing HER2/neu had 
increased development of second tumors when HFD 
was introduced in pubertal mice at 4 weeks of age [13], 
but tumor incidence was not affected when HFD was 
introduced to adult mice at 10 weeks of age [14], again 
suggesting the importance of timing in HFD exposure. In 
this regard, the human epidemiological study by Linos 
et al. [15] specifically indicates adolescent exposure to 
total dietary fat as a risk factor for premenopausal breast 
cancer, while not finding a significant association with 
subtypes of fat.
DMBA must be introduced to mice during puberty 
to efficiently initiate mammary tumors. In our prior studies 
[12], some of the effects of pubertal HFD observed in the 
pre-tumor mammary gland were only evident if the mice 
also received pubertal DMBA exposure. To circumvent 
the potential confounding interaction of pubertal HFD 
with pubertal DMBA exposure, the present study 
investigated the effects of pubertal versus adult exposure 
to HFD on mammary tumorigenesis in obesity resistant 
BALB/c mice, using the Trp53-null transplantation 
model. Trp53 is one the most frequently mutated genes 
in human breast cancer [16, 17]. We found in this model 
that both pubertal and adult life stages were susceptible to 
the promotional effects of HFD. Puberty-restricted HFD 
exposure promoted tumor cell proliferation, increased 
angiogenesis, and increased recruitment of total and M2 
macrophages in epithelial tumors, similarly to adult-
restricted exposure to HFD. Adult HFD exposure uniquely 
increased the occurrence of estrogen and progesterone 
receptor negative (ER- PR-), poorly differentiated spindle 
cell carcinomas. These findings further implicate HFD as 
a risk factor in the occurrence of mammary cancer.
RESULTS
Either pubertal or adult exposure to HFD 
promotes tumorigenesis
In our previous studies in the DMBA mammary 
tumorigenesis model [11, 12], we observed key 
differences in the properties of early versus late occurring 
tumors in response to dietary regimen. Kaplan-Meier 
analysis revealed that the one-year mammary tumor 
incidence in mice receiving Trp53-null mammary 
transplants (Figure 1A) was significantly increased by 
puberty-restricted HFD (HFD-LFD, 39%; 2.2-fold; 
p=0.042), as well as by adult-restricted HFD (LFD-
HFD, 47%; 2.6-fold; p=0.009) compared to LFD (17%). 
Continuous HFD also caused a 1.7-fold increase in 
tumor incidence by one year of age, but the difference 
did not reach statistical significance (HFD 31%; p=0.16). 
Following tumor development up to 500 days of age at 
the end of the study (Figure 1B) showed tumor incidence 
was increased by continuous HFD (HFD, 81%; 1.8-fold; 
p=0.046) and adult-restricted HFD (LFD-HFD, 89%; 
2-fold; p=0.006) compared to continuous LFD (54%); 
the tumor promotional effects of puberty-restricted HFD 
(HFD-LFD, 70%; 1.6-fold; p=0.13) were less dramatic 
when viewed over the longer time course and also showed 
a trend toward increased tumor incidence. Kaplan-Meier 
analysis found no significant differences in tumor latency 
by diet treatments (data not shown).
Tumor characteristics
Tumors of multiple histopathologic types (Figure 2) 
developed in Trp53-null mammary transplants. Regardless 
of the diet treatment, the majority of tumors were 
epithelial in composition. However, some of the tumors 
were poorly differentiated spindle cell carcinomas. LFD-
HFD mice had a significantly increased number of spindle 
cell carcinomas per transplant compared to mice on other 
dietary regimens (p=0.02) (Figure 2A). The majority 
of the epithelial tumors (63-82% among the dietary 
regimens) were ER- PR- and did not vary significantly 
by histological type or diet treatment, and all spindle cell 
tumors were ER- PR- (Supplementary Table S1). The 
majority of the spindle cell tumors also lacked expression 
of keratins 5 and 18, markers of luminal differentiation 
(data not shown).
In quantifying various properties of the tumors in 
the current study, in addition to comparisons between 
tumors arising under the four dietary regimens, we 
compared early (<52 weeks latency; mean latency 42 
weeks, 6.7 weeks SD) versus later occurring (≥52 weeks; 
mean latency 59 weeks, 4.3 weeks SD) epithelial tumors. 
This separation into early versus late developing tumors 
distinguished between the time period where mice fed 
HFD-LFD showed significantly higher tumor incidence 
and the longer time period where significance was not 
observed (see Figure 1). We also compared epithelial 
tumors to spindle cell tumors. For the latter group, we did 
not distinguish between early and late occurring tumors 
because of the limited number of tumors.
Since uncontrolled proliferation and escape from 
apoptosis are hallmarks of cancer, we measured tumor 
cell proliferation and apoptosis by quantifying nuclear 
localization of proliferating cell nuclear antigen (PCNA) 
and terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL), respectively. ANOVA (Supplementary 
Table S2) found that dietary effects on proliferation 
were significant, whether examining both epithelial and 
spindle cell tumors or epithelial tumors alone. While time 
of epithelial tumor onset and identification as a spindle 
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cell tumor were not significant in regard to proliferation, 
a significant interaction was found between diet and 
time of epithelial tumor onset. HFD, HFD-LFD, and 
LFD-HFD mice all exhibited significantly increased 
proliferation in late occurring epithelial tumors (2.2 to 
2.6-fold) and HFD and HFD-LFD spindle cell tumors 
(1.6 to 2.0-fold) compared to tumors from LFD mice 
(Figure 3A). In early occurring epithelial tumors, 
increased proliferation was observed for HFD-LFD 
and LFD-HFD mice, but not for HFD mice. To see if 
enhanced proliferation was specific to tumor cells, we 
also measured the effect of diet on proliferation in normal 
Trp53-null transplanted tissue. No significant effects on 
proliferation were observed in normal tissue of 19-week 
old mice, prior to the appearance of any tumors (data 
not shown). ANOVA (Supplementary Table S2) found 
that dietary effects on apoptosis were significant when 
examining both epithelial and spindle cell tumors. An 
interaction between diet and time of epithelial tumor 
onset approached significance (p=0.09). Apoptosis was 
significantly decreased in HFD and LFD-HFD mice 
(Figure 3B).
Figure 1: The effect of the various dietary regimens on the number of tumor-free mammary glands over time. Kaplan-
Meier plots were determined for BALB/c mice receiving Trp53-null mammary transplants and fed a lifelong LFD (LFD; n= 37 glands), a 
lifelong HFD (HFD; n= 46), a puberty-restricted HFD (HFD-LFD, n=42), and an adult-restricted HFD (LFD-HFD, n=38). A. The number 
of tumor-free mammary glands over one year was significantly reduced in mice fed HFD-LFD and LFD-HFD. (Log-rank tests, LFD vs. 
HFD, p = 0.158; LFD vs. HFD-LFD, *, p = 0.042; LFD vs. LFD-HFD, **, p = 0.009). B. The number of tumor-free mammary glands over 
500 days was significantly reduced by HFD and LFD-HFD, but not HFD-LFD. (Log-rank tests, LFD vs. HFD, *, p = 0.046; LFD vs. HFD-
LFD, p = 0.131; LFD vs. LFD-HFD, **, p = 0.006).
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Because HFD was associated with increased 
angiogenesis in DMBA-induced tumors, we analyzed 
intra-tumoral vascularization with the endothelial cell 
marker, CD31. ANOVA (Supplementary Table S2) found 
that dietary effects on vascularization were significant, 
whether examining both epithelial and spindle cell tumors 
or epithelial tumors alone. Further, time of epithelial 
tumor onset and identification as a spindle cell tumor were 
also significant in regard to vascularization, but epithelial 
tumor onset by itself was not significant, indicating that 
spindle cell tumors differed from epithelial tumors. No 
significant interaction was observed between diet and 
time of epithelial tumor onset and identification as a 
spindle cell tumor. Epithelial tumors on all regimens that 
included HFD showed significant 1.6 to 1.7-fold increased 
vascularization compared to mice fed LFD (Figure 4A). 
Among spindle cell tumors, only those occurring in 
HFD mice showed an increase in vascularization that 
approached significance (p=0.06). Spindle cell tumors 
showed significant 1.3-fold increased vascularization 
compared to epithelial tumors (Figure 4B). No significant 
effects on vascularity were observed in normal tissue of 
19-week old mice, prior to the appearance of any tumors 
(data not shown).
Macrophages play important roles in normal 
mammary development and tumorigenesis [18, 19]. 
We examined both intra-tumor macrophage (F4/80+) 
localization and the extent of M2 (i.e., Arginase 1 positive 
(Arg1+)) polarization in these macrophages. ANOVA 
(Supplementary Table S2) found that dietary effects on 
both total and M2 macrophage levels were significant, 
whether examining both epithelial and spindle cell tumors 
or epithelial tumors alone. While time of epithelial tumor 
onset and identification as a spindle cell tumor were not 
significant in regard to macrophage levels, an interaction 
approaching significance was found between diet and time 
of epithelial tumor onset for total macrophages (p=0.09). 
Among epithelial tumors, significantly increased numbers 
of total (Figure 5A) and M2 (Figure 5B) macrophages 
were observed under all diet regimens that included a 
period of HFD exposure compared to continuous LFD. 
There were no significant dietary effects among spindle 
cell tumors (data not shown). The majority of macrophages 
were Arg1- (i.e., likely M1, classically activated) in all 
tumors across all diet treatments (data not shown). While 
HFD-related increases in total macrophages ranged from 
1.7 to 2.3-fold, it is noteworthy that increases in M2 
macrophages ranged from 2.8 to 6.8-fold (HFD-LFD: 6.8-
Figure 2: Proportions of tumors by histopathology across the different dietary regimens in BALB/c mice receiving 
Trp53-null mammary transplants. A. LFD-HFD increased the proportion of spindle cell carcinomas by 2.7-fold compared to LFD (p 
= 0.02). B-D. Representative H&E stained sections of epithelial, spindle cell and adenosquamous tumors. Scale bar = 0.25mm.
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fold; LFD-HFD: 3.7-fold; HFD: 2.8-fold). At 19-weeks of 
age, HFD-LFD mice showed a 1.9-fold increase (p=0.091) 
in the number of macrophages in normal mammary gland 
over that found for LFD mice (Supplementary Figure 
S1). The overwhelming majority (85 to 91%) of these 
macrophages were of a M2 phenotype (data not shown).
Microarray analysis of gene expression in tumors
The tumor samples from the individual dietary 
regimens did not show significant gene expression 
changes according to specific dietary regimen, due to 
small sample size (n=8 for epithelial tumors, n=3 for 
spindle cell carcinomas; data not shown). Considering 
pubertal HFD exposure, a microarray analysis comparing 
HFD + HFD-LFD versus LFD + LFD-HFD tumors (false 
discovery rate (FDR)=0.10) identified 55 upregulated 
genes (GEO: GSE74294), but no significant canonical 
pathways or molecular functions were identified (data 
not shown). Comparison of early occurring epithelial 
tumors to late occurring epithelial tumors (FDR=0.10), 
irrespective of diet, identified a number of differentially 
Figure 3: Effects of various dietary regimens on tumor proliferation and apoptosis. A. HFD at any life stage tended to 
increase expression of the proliferation marker PCNA in late occurring epithelial and spindle cell tumors (*, p < 0.05). LFD versus LFD-
HFD in spindle cell tumors, p = 0.067. LFD versus HFD in early occurring epithelial tumors was not significant. Tumors are grouped by 
epithelial and spindle cell histology. Epithelial tumors are additionally grouped by latency: early tumors had latencies less than one year; 
late tumors had latencies of one year or greater. Early tumors: LFD (n=5); HFD (n=8); HFD-LFD (n=6); LFD-HFD (n=8). Late tumors: 
LFD (n=5); HFD (n=5); HFD-LFD (n=6); LFD-HFD (n=3). Spindle cell tumors: LFD (n=5); HFD (n=5); HFD-LFD (n=6); LFD-HFD 
(n=6). B. Lifelong HFD (HFD) and adult-restricted HFD (LFD-HFD), irrespective of either latency or histopathology, decreased apoptosis 
as measured by TUNEL labeling (*, p < 0.05). LFD (n=15); HFD (n=18); HFD-LFD (n=18); LFD-HFD (n=17).
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regulated molecular functions (Supplementary Table 
S3). The three most statistically significant were 
“Immunological Disease: systemic autoimmune 
syndrome” (p=9.18E-13), “Endocrine System Disorders, 
Gastrointestinal Disease, Immunological Disease, 
Metabolic Disease: insulin-dependent diabetes mellitus” 
(p=8.51E-14), and “Endocrine System Disorders, 
Gastrointestinal Disease, Metabolic Disease: diabetes 
mellitus” (p=9.18E-13). Comparison of spindle cell 
tumors to the various epithelial tumors (FDR=0.05) 
revealed 1594 significantly upregulated and 1840 
significantly downregulated genes (GEO: GSE74294), 
but no significant canonical pathways were identified 
and, while some significantly upregulated molecular 
functions were identified, none of these molecular 
functions had levels of significance approaching those of 
molecular functions identified in the comparison of early 
to late epithelial tumors (data not shown).
Dietary effects on metabolic parameters
BALB/c mice were previously reported to be 
obesity resistant on HFD [11]. In the present study, we 
observed modest weight gain in HFD and LFD-HFD 
mice (Figure 6). However, the weight gain was neither 
correlated with altered non-fasting plasma glucose 
levels (Figure 7A) nor non-fasting plasma insulin levels 
(Figure 7B) in tumor-bearing mice. As the mice aged, 
there was a trend towards increased plasma glucose 
levels, but not plasma insulin levels, in all diet groups 
(data not shown). In 19-week old mice, prior to the 
appearance of any tumors, glucose and insulin levels 
Figure 4: Effects of dietary regimens on tumor vascularity. A. Among epithelial tumors, HFD at any life stage tended to 
increase blood vessel density as measured by CD31 staining (*, p<0.05). No significant effects were observed among spindle cell 
tumors. Epithelial tumors: n=8 for each dietary group. Spindle cell tumors: n=4 for each dietary group. B. Spindle cell tumors were 
more vascularized than epithelial tumors (*, p<0.05). Epithelial tumors: n=32; Spindle cell tumors: n=16.
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Figure 5: Quantitation of macrophages within epithelial tumors. A. HFD at any life stage increased total macrophages as 
measured by F4/80 staining (*, p<0.05). B. HFD at any life stage increased M2 macrophages as measured by F4/80-Arg1 double staining 
(*, p<0.05). For both panels A and B, LFD (n=9); HFD (n=9); HFD-LFD (n=8); LFD-HFD (n=8).
Figure 6: Body weight over time. Mice fed lifelong HFD had increased body weight compared to mice fed lifelong LFD after 7 weeks on 
diet, while adult-restricted HFD mice (LFD-HFD) had increased body weight 7 weeks after their diet was switched to HFD. Puberty-restricted 
HFD mice (HFD-LFD) had similar weights to those fed lifelong LFD. The weight gains in mice fed HFD and LFD-HFD were 14±8 % and 
17±9 %, respectively, by end of the experiment at 71 weeks of age. LFD mice (n=33); HFD mice (n=31); HFD-LFD (n=31); LFD-HFD (n=31).
Oncotarget83416www.impactjournals.com/oncotarget
were similar between dietary groups (Supplementary 
Figure S2).
DISCUSSION
In Trp53-null initiated tumors, we have identified 
two different life stage periods of increased tumor 
development in response to HFD. Puberty-restricted 
HFD (HFD-LFD) was sufficient to increase tumor 
incidence in mice at one year of age, but the magnitude 
of this promotional effect diminished over a longer time 
frame. Despite switching to LFD in adulthood, the short 
7 weeks of pubertal HFD exposure promoted tumor 
cell proliferation, increased angiogenesis, and increased 
recruitment of total and M2 macrophages in epithelial 
tumors, similarly to adult-restricted exposure to HFD.
Trp53-null initiated tumors were also promoted 
by adult-restricted HFD. This differs from our findings 
on HFD exposure in the DMBA model, where pubertal 
exposure was required for enhanced tumorigenesis [11, 
12]. It is possible that this difference has a basis in Hras1 
being a common mutational target in DMBA-induced 
mammary tumorigenesis [20-22], while Trp53-null 
mutations may reduce the occurrence of Hras1-mutant 
tumors [23]. It is also plausible that the longer time 
course of tumorigenesis for the Trp53-null tumors simply 
provides a longer window for adult HFD effects to occur 
than does the shorter window for adult HFD exposure in 
the DMBA model. Over a longer 500-day time frame, 
adult-restricted HFD and lifelong HFD initiated in puberty 
significantly increased tumor incidence. Among epithelial 
tumors, in addition to promoting tumor cell survival by 
Figure 7: Effects of dietary regimens on plasma levels of glucose and insulin. Non-fasting plasma A. glucose and B. insulin 
levels were measured in tumor bearing mice. No significant differences were found between dietary regimens. LFD (n=8); HFD (n=8); 
HFD-LFD (n=8); LFD-HFD (n=8).
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reducing apoptosis, lifelong and adult-restricted HFD 
also enhanced angiogenesis, and increased recruitment 
of total and M2 macrophages. Unlike puberty-restricted 
HFD exposure, lifelong exposure to HFD did not increase 
tumor cell proliferation. In addition to increasing overall 
mammary tumor incidence, only adult-restricted HFD, 
among the dietary regimens, significantly increased the 
incidence of spindle cell carcinoma, which was previously 
characterized to have many features of epithelial-to-
mesenchymal transition (EMT) and a gene expression 
profile similar to the claudin-low (CL) intrinsic subtype 
of human breast cancer [24]. About 65-80% of CL human 
breast cancers are reported to be ER- PR- and lacking 
expression of keratins 5 and 18 [25]. With our Trp53-null 
mammary transplant model, all spindle cell carcinomas 
were ER- PR-, and the majority lacked keratin 5 and 
18 expression. Genomic analysis of CL breast cancer 
identified a high level of genomic instability with many 
gains and losses. This suggests that CL tumors are likely 
driven by several oncogenic events. It is noteworthy that 
both lifelong and adult-restricted HFD mice experience 
lengthy exposure to HFD, yet the dramatic increase 
in spindle cell carcinoma is specific to adult-restricted 
HFD. Examination of macrophage levels in pre-tumor 
mammary glands showed that macrophage levels were 
elevated in mice exposed to a puberty-restricted HFD 
(i.e., HFD-LFD; p=0.091) and showed a similar trend in 
mice with lifelong HFD. Perhaps this early increase in 
the number of macrophages prior to tumor occurrence 
partially suppresses the occurrence of spindle cell 
carcinomas under lifelong and puberty-restricted HFD 
regimens, while adult-restricted HFD mice, having fewer 
macrophages in pre-tumor tissue, are more permissive for 
their occurrence.
The defining characteristic of puberty-restricted 
HFD is heightened recruitment of M2 macrophages to the 
normal mammary epithelium prior to tumor development. 
Heightened recruitment to normal epithelium was 
initially observed in our earlier studies of the effects of 
puberty-restricted HFD in both the presence of DMBA 
and in the absence of a tumor-inducing agent [12], and is 
reiterated in these current studies in the Trp53-null mouse 
model. This may indicate a critical role of macrophages 
in puberty, as well as the sensitivity of puberty to HFD 
effects. In this regard, macrophages are indeed known to 
be essential for pubertal mammary gland development 
[18]. Furthermore, Trp53-null tumors occurring in mice 
exposed to puberty-restricted HFD show the highest levels 
of both total and M2 macrophage recruitment among 
tumors occurring across the several dietary regimens. 
This was also the case in DMBA-induced mammary 
tumorigenesis [12]. Tumor-associated M2 macrophages 
are known to promote the growth of tumors through 
support of angiogenic and tissue remodeling processes, 
as well as immune suppression [26]. Their presence at 
early pre-neoplastic stages in tumor development suggest 
a critical role in tumorigenesis [27].
The defining characteristic of adult-restricted HFD 
is heightened occurrence of spindle cell carcinoma, which 
resembles CL human breast cancers. As noted above, this 
may be an inverse function of macrophage recruitment. 
The various dietary regimens did not differentially 
affect spindle cell carcinoma proliferation, apoptosis, 
or vascularization. It is also unlikely that the increased 
incidence of spindle cell carcinoma with adult-restricted 
HFD is a consequence of the metabolic effects of extended 
HFD exposure, as similar levels of plasma and glucose 
were observed across all dietary regimens.
Pathway analysis based on RNA expression of the 
tumors found that early occurring tumors upregulated 
molecular functions associated with type 1 diabetes and 
systemic autoimmune syndrome. The genes identified 
across these molecular functions are almost completely 
identical and, while associated with the pathology of 
diabetes, are genes more generally associated with 
autoimmune activity. Previous studies have implicated p53 
in immune regulation. A functional Trp53 polymorphism 
is associated with susceptibility to several autoimmune 
disorders, including systemic lupus erythematosus [28-
31], Hashimoto’s thyroiditis [32], and rheumatoid arthritis 
[33]. Most relevant to the current study, somatic Trp53 
mutations were identified in the synovia of rheumatoid 
arthritis patients [34-38], pointing to the function of p53 
in non-immune cells in the etiology of autoimmunity. A 
likely mechanism for a Trp53-null genotype mediating 
enhanced autoimmune activity is dysregulation of 
apoptosis. For example, Trp53 drives epithelial CD200 
expression, which reduces immune reactivity to apoptotic 
self-antigens [39]. Another apoptotic related function of 
Trp53 is the induction of the pro-apoptotic death domain 
1α protein (DD1α), which is involved in macrophage 
recognition and clearance of apoptotic cells [40]. DD1α-
deficient mice show autoimmunity and inflammation 
associated with their inability to clear apoptotic cells. 
Consistent with the modulation of apoptosis with age, 
ANOVA performed on TUNEL values found an interaction 
between diet and time of epithelial tumor onset that 
approached significance. Future studies should evaluate 
whether failure to express CD200 and/or DD1α may be the 
basis for enhanced autoimmunity under Trp53-deficiency. 
Further, it should be noted that that dietary treatments 
were largely without effect on glucose and insulin 
levels, highlighting the immune rather than metabolic 
significance of the identified molecular functions. It is 
interesting that increased autoimmune activity is identified 
in early versus later occurring tumors. An age-related 
decline in T cell activity is well-established in mouse 
models (reviewed in [41]). At the same time, there is also 
an increased abundance of immunosuppressive Treg cells 
with age (reviewed in [42]).
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We previously reported that a puberty-initiated 
lifelong HFD decreased DMBA-induced tumor latency, 
partly by increasing tumor proliferation, angiogenesis 
and recruitment of M2 macrophages [11]. Recently, we 
reported that only puberty-restricted HFD, but not adult-
restricted HFD, promoted DMBA-induced tumors [12]. A 
similar pubertal sensitivity to HFD was identified in the 
MMTV-neu model, where only puberty-initiated HFD 
promoted development of second tumors [13]. However, 
here we find that HFD confers similar changes in 
proliferation, angiogenesis, and macrophage recruitment 
to Trp53-null initiated tumors, when given either only in 
puberty or only in adulthood. This discrepancy in the life 
stage-related effects of HFD between tumor models might 
be caused by differential sensitivity to HFD between 
tumor subtypes. Indeed, recent human epidemiological 
studies suggest that this may be the case in humans [7]. In 
the DMBA carcinogenesis model, a significant proportion 
of the early developing tumors from mice fed a puberty-
restricted HFD were adenosquamous carcinomas [11, 
12], which are rare in the Trp53-null transplant model. 
In contrast, the spindle cell carcinomas promoted by 
adulthood-restricted HFD in the Trp53-null transplant 
model are rare in other murine carcinogenesis models 
[24].
A limited number of randomized, controlled studies 
of dietary intervention to prevent breast cancer have been 
carried out with mixed conclusions. One study that focused 
on women with high mammographic density found no 
reduction in breast cancer risk with reduced dietary fat 
[43]. Another study focusing on post-menopausal women, 
while finding no significant protective effect for low fat 
intervention, reported a trend toward a protective effect 
in women with highest baseline fat intake [44]. However, 
these women also showed significant weight loss with low 
fat intervention, so it is unclear whether the benefit is from 
low fat in itself or from decreased body mass index (BMI). 
Here, we found that switching mice from a pubertal HFD 
to an adult LFD does not confer short-term protective 
effects. Puberty-restricted HFD mice showed increased 
incidence of mammary tumors over LFD mice during 
the initial year of our study. Over a longer time course of 
500 days, the difference in incidence of mammary tumors 
in puberty-restricted HFD and LFD mice became less 
significant. Whether this reflects a reduction in the risk 
posed by pubertal HFD or alleviation of adult-specific 
dietary risk is unclear because adult-restricted HFD poses 
a significant risk in itself. Nonetheless, the existence 
of tumor promotional effects by HFD at both puberty 
and adulthood, and the potential to alleviate the HFD-
associated risk demonstrated in this study, offer hope for 
using dietary intervention as a breast cancer prevention 
strategy. However, the profound effects of pubertal 
exposure to HFD on tumor development highlight the 
importance of successful dietary intervention programs 
and the need for early life intervention strategies.
Obesity/high BMI (BMI > 30 kg/m2) is a well-
established risk factor for post-menopausal breast 
cancer [45]. However, normal weight women who 
consume high saturated fat and high animal fat diets 
have increased pre-menopausal breast cancer risk [8]. 
In the current study, modest weight gains of 14-17% 
were observed in BALB/c mice fed puberty-initiated 
lifelong and adult-restricted HFD. This modest weight 
gain is consistent with previous studies in BALB/c 
mice demonstrating their resistance to HFD-induced 
obesity [11, 12, 46]. In the absence of obesity, both 
puberty- and adult-restricted HFD enhanced tumor 
cell proliferation [11, 12]. In a similar non-obesogenic 
context, HFD stimulated growth of injected 4T1 cells 
in BALB/c mammary fat pads, and promoted liver and 
lung metastases [47]. Collectively, our findings and 
those of others suggest that a diet rich in animal fat may 
promote proliferation in mammary tumors. Our earlier 
studies found that HFD also stimulated proliferation 
in normal mammary epithelium [11, 12, 46], however 
we did not observe this in the current study. The earlier 
studies examined mice at 7 and 13 weeks of age, while 
the current study examined normal epithelium at 19 
weeks of age. The proliferative response of normal 
epithelium to HFD may be a property of puberty. We 
found that mice at 7 and 13 weeks of age have higher 
basal levels of mammary epithelial proliferation than 
do mice at 19 weeks of age. Thus, HFD may induce 
increased proliferation during developmental stages 
when the mammary epithelium is already proliferating.
These studies show that exposure to HFD restricted 
to either puberty or adulthood is sufficient to promote 
Trp53-null mammary tumorigenesis in the absence of 
obesity. This confirms our earlier studies [11, 12] that 
identified puberty as a life stage particularly sensitive 
to the promotional effects of HFD in mammary 
tumorigenesis, and extends these findings to identify 
adulthood as an independent period of sensitivity to 
HFD given an appropriate oncogenic initiator. Notably, 
adult-restricted HFD not only increased the incidence of 
mammary tumors, but specifically increased the incidence 
of spindle cell carcinomas that resemble CL breast cancer, 
suggesting that this may be a useful animal model for 
human CL breast cancer. Epithelial tumors that developed 
in mice fed HFD at any life stage showed varying 
levels of enhanced tumor proliferation, angiogenesis, 
and macrophage recruitment, all plausible contributors 
to tumor promotion. Importantly, the identification 
of puberty as a particularly sensitive life stage for the 
promotional effects of HFD indicates the potential of an 





BALB/c Trp53+/- breeding mice were obtained from 
Dr. D. Joseph Jerry (University of Massachusetts, Amherst 
MA), and Trp53-null mice were generated as described 
[48]. The Trp53-null tissue donor mice were maintained 
on chow diet before mammary gland collection at eight 
weeks of age. Wild-type recipient female BALB/c mice 
were purchased from Charles River (Portage, MI) at 3 
weeks of age. Mice were randomly assigned into four 
diet groups (see Diets). Food and water were provided 
ad libitum. Animals were housed in a standard laboratory 
housing environment with a 12:12 h light–dark cycle, at 
20 to 24°C with 40 to 50% relative humidity. All animal 
experimentation was conducted in accord with accepted 
standards of humane animal care under guidelines 
approved by the All University Committee on Animal 
Use and Care at Michigan State University (AUF #09/14-
176-00).
Trp53-null mouse model
Fragments of donor mammary epithelium were 
collected from female BALB/c Trp53-null mice at 8 
weeks of age, and transplanted into the cleared inguinal 
mammary fat pads of 3-week-old female wild type mice 
as previously described [49, 50]. To minimize donor 
bias from secondary genetic alterations, mammary 
duct fragments from 4 donor mice were transplanted to 
recipient mice in each diet group in equal distribution. 
Body weights and food consumption were monitored 
weekly. Animals were palpated for tumor development 
twice a week starting at 13 weeks of age. Tumors 
were harvested at 1 cm in diameter. Portions of tumors 
and mammary glands were formalin-fixed, paraffin 
embedded for H&E and immunohistochemistry, and the 
remaining portions of tumors were snap-frozen for later 
RNA isolation. Mice were monitored for 500 days, and 
at termination of the studies, mammary glands were 
formalin-fixed and processed as whole mounts to evaluate 
transplantation success rate. Transplantation success rates 
were 59%, 77%, 64% and 72% for the LFD, HFD, LFD-
HFD, HFD-LFD groups, respectively. Mammary glands 
that had no epithelium present were excluded from the 
analysis of tumor incidence. See Supplementary Table S4 
for further detail on mammary gland transplantation and 
occurrence of mammary tumors.
Diets
Low fat diet (D11012202; 10% kcal fat) and high 
fat diet (D11012204; 60% kcal fat) were purchased from 
Research Diets (New Brunswick, NJ). See Supplementary 
Table S5 for detailed composition of the diets. For the 
continuous LFD and HFD groups, diets were initiated 
after transplantation at 3 weeks of age and maintained 
throughout the studies. For the HFD-LFD and LFD-HFD 
groups, mice were initially fed one diet from 3 weeks 
until 10 weeks of age, and then switched to the other diet 
thereafter (Figure 8).
Immunohistochemistry
5 μm tumor sections were deparaffinized and 
rehydrated, as previously described [11]. Antigen 
retrieval was accomplished by autoclaving at 121°C 
Figure 8: Experimental scheme. Fragments of Trp53-null mammary duct were transplanted into cleared fat pads of female 3-week-old 
wild-type BALB/c mice. After the surgery, mice were randomly assigned to four diet groups. The LFD group (n=33) and the HFD group 
(n=31) were fed their respective diets lifelong and ad libitum. To investigate the effects of HFD exposure restricted to puberty, a group 
of HFD-fed mice (n=31) were switched to LFD (HFD-LFD) at 10 weeks of age. Similarly, to investigate the effects of HFD exposure 
restricted to adulthood, a group of LFD-fed mice (n=31) were switched to HFD (LFD-HFD) at 10 weeks of age. Tumor development was 
monitored until mice reached 500 days (71 weeks) of age.
Oncotarget83420www.impactjournals.com/oncotarget
and 15 psi for 30 minutes in citrate buffer (pH 6.0). 
For blood vessel density determinations, CD31 was 
detected with rabbit polyclonal anti-CD31 (1:50 in 
PBS–0.5% Triton X-100; Cat #: AP15436PU-N; Acris 
Antibodies, Inc., San Diego, CA) at RT for 2 hours. 
Images were captured using a Nikon Eclipse E400 light 
microscope (Nikon, Inc., Melville, NY) with a 40X 
objective lens. The images were overlaid with grids 
containing 240 squares (324 μm2/square). Blood vessel 
density is expressed as the percentage of CD31-positive 
squares. For proliferation, PCNA was detected using 
goat polyclonal anti-PCNA (1:100 in PBS–0.5% Triton 
X-100; Cat #: sc-9857; Santa Cruz, Biotechnology, Inc., 
Santa Cruz, CA) at 4°C overnight. For macrophage 
detection, double staining of F4/80 and Arg1 has 
been described previously [11] using monoclonal rat 
anti-F4/80 (1:75 in PBS–0.5% Triton X-100; Cat #: 
MCA497R; AbD Serotec, Raleigh, NC) and goat anti-
Arg1 (1:200 in PBS–0.5% Triton X-100; Cat #: sc-
18354; Santa Cruz Biotechnology, Inc.). Detection of 
ERα and PR was performed as previously described [11]. 
ERα was detected with mouse anti-ERα (1:10 in PBS–
0.5% Triton X-100; Cat #: NCL-ER-6F11; Novocastra 
Laboratories, Ltd, Newcastle upon Tyne, UK) and PR 
was detected with rabbit anti-PR (1:200 in 2% BSA 
in phosphate-buffered saline; Cat #: A0092; DAKO, 
Carpinteria, CA). Cytokeratin 18 (K18) was detected 
with mouse anti-cytokeratin 18 (1:75 in PBS–0.5% 
Triton X-100; Cat #ab668; Abcam, Cambridge, MA) and 
cytokeratin 5 (K5) with rabbit anti-cytokeratin 5 (1:500 
in PBS–0.5% Triton X-100; Cat # 905501; BioLegend, 
San Diego, CA). Immunofluorescent staining was 
completed with appropriate secondary antibodies. All 
immunofluorescence sections were counterstained with 
4’,6-diamidino-2-phenylindole (DAPI) to visualize 
nuclei. Images were captured with a Nikon Eclipse 
TE2000-U fluorescence microscope (Nikon, Inc.) 
using a 40x objective. At least 1000 cells and at least 
3 sections per animal were analyzed. For proliferation, 
cells were scored positive with the presence of speckled 
nuclear localization of PCNA [51]. Macrophage density 
was expressed as the number of F4/80 positive cells per 
tumor image. For ERα and PR assessment, a minimum 
of 1000 cells were counted for each tumor. Tumors were 
considered to be ERα+ if 10% or more of the total cells 
counted were ERα+ [52]; a minimum of 500 cells per 
section for each tumor were counted.
TUNEL
5μm tumor sections were deparaffinized and 
rehydrated. TUNEL analysis was performed using the 
TdT-FragEL DNA Fragmentation Detection Kit (EMD 
Millipore, Billerica, MA) following the manufacturer's 
directions. At least 1000 cells and at least 3 sections per 
animal were analyzed.
Metabolic parameters
Plasma glucose and insulin levels were measured 
from samples collected at sacrifice from non-fasting 
tumor-bearing animals, as previously described [11]. 
Plasma glucose levels were determined by OneTouch 
UltraMini (LifeScan, Inc., Milpitas, CA) and the insulin 
levels were determined with the rat/mouse insulin ELISA 
kit (EMD Millipore), according to the manufacturer’s 
instructions.
Microarray analysis
Agilent Technologies (Santa Clara, CA) 4X44K 
whole mouse genome microarrays were performed 
according to manufacturer protocol with linear 
amplification and 2-color hybridization using total RNA 
isolated from mouse mammary tumors (Supplementary 
Table S6). The reference channel was Universal Mouse 
Reference (as described in [53]) and was labeled with 
Cy5. Spots that had intensity greater than 10 dpi in 
at least 80% of samples were selected for subsequent 
analysis. Data were Lowess normalized and missing 
data were imputed using k-nearest neighbors with k = 
10. A total of 41 microarrays were analyzed. Two class 
Significance Analysis of Microarrays was performed to 
identify differentially expressed genes between early vs. 
late tumor onset among all tumors and among spindle cell 
and epithelial cell carcinomas separately, pubertal HFD 
vs. LFD, and spindle cell vs. epithelial carcinoma. All 
statistical analyses were conducted in R using the samr 
package in Bioconductor. The cutoff for significance was 
a 0.10 false discovery rate (FDR) for early occurring 
epithelial tumors versus late occurring epithelial tumors 
and for HFD + HFD-LFD versus LFD + LFD-HFD 
tumors. The cutoff for significance was a 0.05 FDR 
for spindle cell tumors versus epithelial tumors. A pre-
set FDR threshold is generally not advised because the 
analysis may result in huge variations in the number of 
candidate genes [54]. An appropriate signature size is 
important in empirical analyses, since either too many or 
too few genes may not provide informative and reliable 
biological interpretations. Based on this consideration, 
we relaxed the FDR threshold for analysis of early versus 
late tumors and for HFD + HFD-LFD versus LFD + 
LFD-HFD tumors to capture more potential biological 
information; while in the analysis of epithelial versus 
spindle cell tumors, where thousands of significant genes 
were identified, a more stringent threshold was used to 
reduce the number of false positive genes. For genes 
significantly associated with early versus late tumor onset, 
gene ontology analyses were conducted using Ingenuity 
Pathway Analysis. All microarray data discussed in this 
publication have been deposited in the National Center 
for Biotechnology Information Gene Expression Omnibus 
(GEO) [55] database and are accessible at accession 
Oncotarget83421www.impactjournals.com/oncotarget
number [GEO: GSE74294] [Puberty-specific promotion 
of mammary tumorigenesis by a high animal fat diet in 
P53 -/- mice http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE74294 Access date: 24 Oct 2015].
Statistical analysis
Results are shown as mean ± standard error of the 
mean (SEM). Differences were considered significant 
at p <0.05 using Student’s t-test or analysis of variance 
(ANOVA) followed by the Tukey multiple comparison 
test, as appropriate. Mammary tumor free survivals were 
determined from Kaplan-Meier plots by log-rank tests. 
Tumor incidence was analyzed by the Chi-square test.
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